Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.

Hoeks M, Yu G, Langemeijer S, Crouch S, de Swart L, Fenaux P, Symeonidis A, Čermák J, Hellström-Lindberg E, Sanz G, Stauder R, Holm MS, Mittelman M, Mądry K, Malcovati L, Tatic A, Almeida AM, Germing U, Savic A, Gredelj Šimec N, Culligan D, Itzykson R, Guerci-Bresler A, Slama B, van de Loosdrecht A, van Marrewijk C, Droste J, Blijlevens N, van Kraaij M, Bowen D, de Witte T, Smith A; EUMDS Registry Participants.

Haematologica. 2019 Jul 5. pii: haematol.2018.212332. doi: 10.3324/haematol.2018.212332. [Epub ahead of print]

2.

Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks.

Saadah NH, Schipperus MR, Wiersum-Osselton JC, van Kraaij MG, Caram-Deelder C, Beckers EAM, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, van der Bom JG.

Haematologica. 2019 Jul 4. pii: haematol.2019.222083. doi: 10.3324/haematol.2019.222083. [Epub ahead of print]

3.

Vox Sanguinis International Forum on paediatric indications for blood component transfusion: Summary.

Bruun MT, Yazer MH, Spinella PC, Titlestad K, Lozano M, Delaney M, Lejdarová H, Pavlova DE, Trakhtman P, Starostin N, Zhiburt E, van Kraaij MGJ, Huisman E, Kutner JM, Sakashita AM, Yokoyama APH, Zubicaray J, Sevilla J, Okazaki H, Hiwatari M, Nagura Y, Manzini PM, Facco G, Avdis C, Singh L, Hans R, Sharma RR, Kumar P, Wikman A, Deschmann E, Kaur H, Mei JLC, Ying SHK, Pei Lin K, New HV, Moss R, Kinmonth A, Comande M, Savoia H, Crighton G, Yacobovich J, Yahalom V, Lau W.

Vox Sang. 2019 Jul;114(5):523-530. doi: 10.1111/vox.12763. Epub 2019 May 13. No abstract available.

PMID:
31087379
4.

Vox Sanguinis International Forum on paediatric indications for blood component transfusion.

Bruun MT, Yazer MH, Spinella PC, Titlestad K, Lozano M, Delaney M, Lejdarová H, Pavlova D, Trakhtman P, Starostin N, Zhiburt E, van Kraaij MGJ, Huisman E, Kutner JM, Sakashita AM, Yokoyama APH, Zubicaray J, Sevilla J, Okazaki H, Hiwatari M, Nagura Y, Manzini PM, Facco G, Pecoraro C, Singh L, Hans R, Sharma RR, Kumar P, Wikman A, Deschmann E, Kaur H, Mei Lam JC, Ying Ho SK, Koh PL, Moss R, New HV, Kinmonth A, Comande M, Savoia H, Crighton G, Yacobovich J, Yahalom V, Lau W.

Vox Sang. 2019 Jul;114(5):e36-e90. doi: 10.1111/vox.12762. Epub 2019 May 13. No abstract available.

PMID:
31087343
5.

Apheresis causes complement deposition on red blood cells (RBCs) and RBC antigen alterations, possibly inducing enhanced clearance.

de Back DZ, Nezjad SG, Beuger BM, Veldhuis M, Clifford E, Ait Ichou F, Berghuis J, Go M, Gouwerok E, Meinderts S, Vrielink H, de Kort W, de Korte D, van Kraaij M, van Bruggen R.

Transfusion. 2018 Nov;58(11):2627-2634. doi: 10.1111/trf.14896. Epub 2018 Sep 28.

PMID:
30265755
6.

A Conceptual Framework for Optimizing Blood Matching Strategies: Balancing Patient Complications Against Total Costs Incurred.

van Sambeeck JHJ, de Wit PD, Luken J, Veldhuisen B, van den Hurk K, van Dongen A, Koopman MMW, van Kraaij MGJ, van der Schoot CE, Schonewille H, de Kort WLAM, Janssen MP.

Front Med (Lausanne). 2018 Jul 25;5:199. doi: 10.3389/fmed.2018.00199. eCollection 2018.

7.

Lessons from the INTERVAL study.

van den Hurk K, van Kraaij MGJ, Zalpuri S.

Lancet. 2018 Jun 30;391(10140):2604-2605. doi: 10.1016/S0140-6736(18)30795-5. No abstract available.

PMID:
30070219
8.

Bone marrow iron score as an indicator for secondary iron overload in acute myeloid leukemia patients.

Hoeks M, van der Pol M, Middelburg R, Evers D, van Kraaij M, Zwaginga JJ.

Eur J Haematol. 2018 Jul 17. doi: 10.1111/ejh.13145. [Epub ahead of print]

PMID:
30014522
9.

A method for red blood cell biotinylation in a closed system.

de Back DZ, Vlaar R, Beuger B, Daal B, Lagerberg J, Vlaar APJ, de Korte D, van Kraaij M, van Bruggen R.

Transfusion. 2018 Apr;58(4):896-904. doi: 10.1111/trf.14535. Epub 2018 Feb 15.

PMID:
29446461
10.

Utility of zinc protoporphyrin in management of whole blood donors.

Schotten N, Zalpuri S, Pasker-de Jong PCM, Swinkels DW, van den Hurk K, de Kort WLAM, van Kraaij MGJ, van Noord PAH.

Transfusion. 2018 Mar;58(3):692-700. doi: 10.1111/trf.14480. Epub 2018 Jan 26.

PMID:
29377138
11.

A 3D spatial spectral integral equation method for electromagnetic scattering from finite objects in a layered medium.

Dilz RJ, van Kraaij MGMM, van Beurden MC.

Opt Quantum Electron. 2018;50(5):206. doi: 10.1007/s11082-018-1471-7. Epub 2018 Apr 19.

12.

Donor base management: painting Gabriel's horn - Comment on Beckman et al., 2016.

de Kort W, van Kraaij M, van den Hurk K.

Transfus Med. 2017 Dec;27(6):460-461. doi: 10.1111/tme.12499. No abstract available.

PMID:
29282808
13.

Red blood cell transfusion support and management of secondary iron overload in patients with haematological malignancies in the Netherlands: a survey.

Hoeks MPA, Middelburg RA, Romeijn B, Blijlevens NMA, van Kraaij MGJ, Zwaginga JJ.

Vox Sang. 2018 Feb;113(2):152-159. doi: 10.1111/vox.12617. Epub 2017 Dec 19.

PMID:
29266372
14.

Patient blood management knowledge and practice among clinicians from seven European university hospitals: a multicentre survey.

Manzini PM, Dall'Omo AM, D'Antico S, Valfrè A, Pendry K, Wikman A, Fischer D, Borg-Aquilina D, Laspina S, van Pampus ECM, van Kraaij M, Bruun MT, Georgsen J, Grant-Casey J, Babra PS, Murphy MF, Folléa G, Aranko K.

Vox Sang. 2018 Jan;113(1):60-71. doi: 10.1111/vox.12599. Epub 2017 Oct 29.

PMID:
29082529
15.

The practice of diagnosing and reporting transfusion-associated circulatory overload: a national survey among physicians and haemovigilance officers.

Bosboom JJ, Klanderman RB, Peters AL, van de Weerdt EK, Goudswaard EJ, Binnekade JM, Zwaginga JJ, Beckers EAM, Geerts BF, Hollmann MW, Zeerleder SS, van Kraaij M, Vlaar AP.

Transfus Med. 2018 Oct;28(5):363-370. doi: 10.1111/tme.12480. Epub 2017 Oct 23.

PMID:
29058354
16.

2D TM scattering problem for finite dielectric objects in a dielectric stratified medium employing Gabor frames in a domain integral equation.

Dilz RJ, van Kraaij MGMM, van Beurden MC.

J Opt Soc Am A Opt Image Sci Vis. 2017 Aug 1;34(8):1315-1321. doi: 10.1364/JOSAA.34.001315.

PMID:
29036095
17.

The effect of World Blood Donor Day on digital information seeking and donor recruitment.

Kranenburg FJ, Kreuger AL, Arbous MS, Laeijendecker D, van Kraaij MGJ.

Transfusion. 2017 Oct;57(10):2458-2462. doi: 10.1111/trf.14228. Epub 2017 Jun 27.

PMID:
28656684
18.

Impact of red blood cell transfusion strategies in haemato-oncological patients: a systematic review and meta-analysis.

Hoeks MPA, Kranenburg FJ, Middelburg RA, van Kraaij MGJ, Zwaginga JJ.

Br J Haematol. 2017 Jul;178(1):137-151. doi: 10.1111/bjh.14641. Epub 2017 Jun 7. Review.

PMID:
28589623
19.

Reporting transfusion-related acute lung injury by clinical and preclinical disciplines.

Peters AL, Van De Weerdt EK, Goudswaard EJ, Binnekade JM, Zwaginga JJ, Beckers EAM, Zeerleder SS, Van Kraaij MGJ, Juffermans NP, Vlaar APJ.

Blood Transfus. 2018 May;16(3):227-234. doi: 10.2450/2017.0266-16. Epub 2017 Apr 5.

20.

EPO and hepcidin plasma concentrations in blood donors and β-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations.

Schotten N, Laarakkers CM, Roelofs RW, Origa R, van Kraaij MG, Swinkels DW.

Am J Hematol. 2017 Mar;92(3):E29-E31. doi: 10.1002/ajh.24636. No abstract available.

21.

The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism.

Schotten N, Pasker-de Jong PC, Moretti D, Zimmermann MB, Geurts-Moespot AJ, Swinkels DW, van Kraaij MG.

Blood. 2016 Oct 27;128(17):2185-2188. Epub 2016 Sep 1. No abstract available.

22.

How we manage patients with hereditary haemochromatosis.

Rombout-Sestrienkova E, van Kraaij MG, Koek GH.

Br J Haematol. 2016 Dec;175(5):759-770. doi: 10.1111/bjh.14376. Epub 2016 Oct 10. Review.

PMID:
27723100
23.

Patient Blood Management in Europe: surveys on top indications for red blood cell use and Patient Blood Management organization and activities in seven European university hospitals.

Bruun MT, Pendry K, Georgsen J, Manzini P, Lorenzi M, Wikman A, Borg-Aquilina D, van Pampus E, van Kraaij M, Fischer D, Meybohm P, Zacharowski K, Geisen C, Seifried E, Liumbruno GM, Folléa G, Grant-Casey J, Babra P, Murphy MF.

Vox Sang. 2016 Nov;111(4):391-398. doi: 10.1111/vox.12435. Epub 2016 Aug 10.

PMID:
27509167
24.

Fast semi-analytical solution of Maxwell's equations in Born approximation for periodic structures.

Pisarenco M, Quintanilha R, van Kraaij MG, Coene WM.

J Opt Soc Am A Opt Image Sci Vis. 2016 Apr 1;33(4):610-7. doi: 10.1364/JOSAA.33.000610.

PMID:
27140770
25.

Course of iron parameters in HFE-hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy.

Rombout-Sestrienkova E, Koek GH, Neslo R, van Kraaij M, Menheere PP, Masclee A, Swinkels DW.

J Clin Apher. 2016 Dec;31(6):564-570. doi: 10.1002/jca.21451. Epub 2016 Feb 16.

PMID:
26878994
26.

Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.

Geisen C, Kann G, Strecker T, Wolf T, Schüttfort G, van Kraaij M, MacLennan S, Rummler S, Weinigel C, Eickmann M, Fehling SK, Krähling V, Seidl C, Seifried E, Schmidt M, Schäfer R.

Vox Sang. 2016 May;110(4):329-35. doi: 10.1111/vox.12376. Epub 2016 Jan 14.

PMID:
26766162
27.

Rare transmission of hepatitis B virus by Dutch donors with occult infection.

Lieshout-Krikke RW, van Kraaij MG, Danovic F, Zaaijer HL.

Transfusion. 2016 Mar;56(3):691-8. doi: 10.1111/trf.13401. Epub 2015 Nov 11.

PMID:
26559665
28.

Erythrocytapheresis versus phlebotomy in the maintenance treatment of HFE hemochromatosis patients: results from a randomized crossover trial.

Rombout-Sestrienkova E, Winkens B, Essers BA, Nieman FH, Noord PA, Janssen MC, van Deursen CT, Boonen A, Reuser-Kaasenbrood EP, Heeremans J, van Kraaij M, Masclee A, Koek GH.

Transfusion. 2016 Jan;56(1):261-70. doi: 10.1111/trf.13328. Epub 2015 Sep 10.

PMID:
26358375
29.

Of macrophages and red blood cells; a complex love story.

de Back DZ, Kostova EB, van Kraaij M, van den Berg TK, van Bruggen R.

Front Physiol. 2014 Jan 30;5:9. doi: 10.3389/fphys.2014.00009. eCollection 2014. Review.

30.

Phosphatidylserine exposure on stored red blood cells as a parameter for donor-dependent variation in product quality.

Dinkla S, Peppelman M, Van Der Raadt J, Atsma F, Novotný VM, Van Kraaij MG, Joosten I, Bosman GJ.

Blood Transfus. 2014 Apr;12(2):204-9. doi: 10.2450/2013.0106-13. Epub 2013 Oct 3.

31.

Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect.

Mathijssen NC, Masereeuw R, Holme PA, van Kraaij MG, Laros-van Gorkom BA, Peyvandi F, van Heerde WL.

Thromb Res. 2013 Aug;132(2):256-62. doi: 10.1016/j.thromres.2013.05.027. Epub 2013 Jul 6.

32.

Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.

van Geffen M, Mathijssen NC, Holme PA, Laros-van Gorkom BA, van Kraaij MG, Masereeuw R, Peyvandi F, van Heerde WL.

Thromb Res. 2013 Jul;132(1):116-22. doi: 10.1016/j.thromres.2013.04.021. Epub 2013 May 31.

PMID:
23731565
33.

Hemoglobin level is positively associated with blood pressure in a large cohort of healthy individuals.

Atsma F, Veldhuizen I, de Kort W, van Kraaij M, Pasker-de Jong P, Deinum J.

Hypertension. 2012 Oct;60(4):936-41. doi: 10.1161/HYPERTENSIONAHA.112.193565. Epub 2012 Sep 4.

PMID:
22949533
34.

Lookback procedures after postdonation notifications during a Q fever outbreak in the Netherlands.

van Kraaij MG, Slot E, Hogema BM, Zaaijer HL.

Transfusion. 2013 Apr;53(4):716-21. doi: 10.1111/j.1537-2995.2012.03792.x. Epub 2012 Jul 13.

PMID:
22803955
35.

[Erythrocytapheresis for hereditary haemochromatosis].

Rombout-Sestrienkova E, van Deursen CT, Janssen MC, van Kraaij MG, de Leeuw PW, Koek GH.

Ned Tijdschr Geneeskd. 2012;156(26):A4745. Dutch.

PMID:
22759710
36.

A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis.

van Geffen M, Loof A, Lap P, Boezeman J, Laros-van Gorkom BA, Brons P, Verbruggen B, van Kraaij M, van Heerde WL.

Hematology. 2011 Nov;16(6):327-36. doi: 10.1179/102453311X13085644680348.

PMID:
22183066
37.

Misleading one-stage coagulation factor assay during rFVIIa treatment in lupus patient.

Herbers AH, Verbruggen B, Van de Veerdonk F, Van Kraaij M, Blijlevens NM, Novakova IR.

Haemophilia. 2009 Sep;15(5):1164-6. doi: 10.1111/j.1365-2516.2009.02061.x. Epub 2009 Jul 7. No abstract available.

PMID:
19601985
38.

Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.

Stevens-Kroef MJ, Schoenmakers EF, van Kraaij M, Huys E, Vermeulen S, van der Reijden B, van Kessel AG.

Leukemia. 2006 Jun;20(6):1187-9. No abstract available.

PMID:
16598304
39.

Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population.

Boekhorst J, Verbruggen B, Lavergne JM, Costa JM, Schoormans SC, Brons PP, van Kraaij MG, Nováková IR, van Heerde WL.

Br J Haematol. 2005 Oct;131(1):109-17.

PMID:
16173970
40.

Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid.

Huvers F, Slappendel R, Benraad B, van Hellemondt G, van Kraaij M.

Neth J Med. 2005 May;63(5):184-6.

41.

Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture.

van Kraaij MG, van Elden LJ, van Loon AM, Hendriksen KA, Laterveer L, Dekker AW, Nijhuis M.

Clin Infect Dis. 2005 Mar 1;40(5):662-9. Epub 2005 Feb 7.

PMID:
15714410
42.

[Diagnostic and pharmaco-therapeutic options in acute severe blood loss].

Kamphuisen PW, Levi M, van Kraaij MG, Kaasjager HA, Frölke JP.

Ned Tijdschr Geneeskd. 2004 Sep 25;148(39):1907-11. Review. Dutch.

PMID:
15495987
43.

Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction.

van Elden LJ, van Loon AM, van Alphen F, Hendriksen KA, Hoepelman AI, van Kraaij MG, Oosterheert JJ, Schipper P, Schuurman R, Nijhuis M.

J Infect Dis. 2004 Feb 15;189(4):652-7. Epub 2004 Jan 28.

PMID:
14767819
44.

Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults.

van Elden LJ, van Loon AM, van der Beek A, Hendriksen KA, Hoepelman AI, van Kraaij MG, Schipper P, Nijhuis M.

J Clin Microbiol. 2003 Sep;41(9):4378-81. Erratum in: J Clin Microbiol. 2005 Aug;43(8):4308.

45.

Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence.

van Kraaij MG, Verdonck LF, Rozenberg-Arska M, Dekker AW.

Bone Marrow Transplant. 2002 Sep;30(5):303-9.

46.

Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia.

van Elden LJ, van Kraaij MG, Nijhuis M, Hendriksen KA, Dekker AW, Rozenberg-Arska M, van Loon AM.

Clin Infect Dis. 2002 Jan 15;34(2):177-83. Epub 2001 Dec 4.

PMID:
11740705
47.

Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia.

Zeylemaker MM, Jaspers CA, van Kraaij MG, Visser MR, Hoepelman IM.

Eur J Clin Microbiol Infect Dis. 2001 Jun;20(6):380-4.

PMID:
11476436
48.

Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients.

van Kraaij MG, Dekker AW, Verdonck LF, van Loon AM, Vinjé J, Koopmans MP, Rozenberg-Arska M.

Bone Marrow Transplant. 2000 Aug;26(3):299-303.

49.

Emergence and infectious complications of ciprofloxacin-resistant Escherichia coli in haematological cancer patients.

van Kraaij MG, Dekker AW, Peters E, Fluit A, Verdonck LF, Rozenberg-Arska M.

Eur J Clin Microbiol Infect Dis. 1998 Aug;17(8):591-2. No abstract available.

PMID:
9796662
50.

Piperacillin/tazobactam therapy for diabetic foot infection.

Zeillemaker AM, Veldkamp KE, van Kraaij MG, Hoekstra JB, Hoynck van Papendrecht AA, Diepersloot RJ.

Foot Ankle Int. 1998 Mar;19(3):169-72.

PMID:
9542990

Supplemental Content

Loading ...
Support Center